{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental+2&page=31", "query": { "intervention": "Experimental 2", "page": 31 }, "page_size": 10 }, "pagination": { "page": 31, "page_size": 10, "total_count": 4112, "total_pages": 412, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental+2&page=32&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental+2&page=30&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-07T19:54:28.082Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06811376", "title": "Pilot Trial of Spiritual Care Interventions for Patients With Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Advanced Cancer" ], "interventions": [ { "name": "Spiritual Care Intervention #1", "type": "BEHAVIORAL" }, { "name": "Spiritual Care Intervention #2", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2025-02-13", "completion_date": "2027-04-01", "has_results": false, "last_update_posted_date": "2026-03-25", "last_synced_at": "2026-11-07T19:54:28.082Z", "location_count": 2, "location_summary": "Brooklyn, New York • Galveston, Texas", "locations": [ { "city": "Brooklyn", "state": "New York" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06811376" }, { "nct_id": "NCT07287085", "title": "Increasing Lung Cancer Screening Uptake Among Emergency Department Patients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Screening Compliance", "Lung Cancer (Diagnosis)", "Lung Cancer Diagnosis", "Lung Cancer" ], "interventions": [ { "name": "Facilitated referral and text messaging", "type": "BEHAVIORAL" }, { "name": "Basic Referral (enhanced control arm)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "50 Years to 80 Years" }, "enrollment_count": 349, "start_date": "2026-03-18", "completion_date": "2028-11", "has_results": false, "last_update_posted_date": "2026-05-04", "last_synced_at": "2026-11-07T19:54:28.082Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07287085" }, { "nct_id": "NCT05817643", "title": "Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease", "Dementia" ], "interventions": [ { "name": "BMS-984923", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allyx Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "50 Years to 80 Years" }, "enrollment_count": 12, "start_date": "2023-01-10", "completion_date": "2024-11-15", "has_results": false, "last_update_posted_date": "2024-07-30", "last_synced_at": "2026-11-07T19:54:28.082Z", "location_count": 1, "location_summary": "West Bend, Wisconsin", "locations": [ { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05817643" }, { "nct_id": "NCT04516447", "title": "A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumor", "Epithelial Ovarian Cancer", "Fallopian Tube Cancer", "Peritoneal Cancer" ], "interventions": [ { "name": "Azenosertib", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Pegylated liposomal doxorubicin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Bevacizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 172, "start_date": "2020-10-26", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-11-07T19:54:28.082Z", "location_count": 8, "location_summary": "Aurora, Colorado • Boston, Massachusetts • St Louis, Missouri + 5 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04516447" }, { "nct_id": "NCT04443114", "title": "Informing American Muslims About Living Donation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Living Organ Donation" ], "interventions": [ { "name": "Organ Donation Workshop", "type": "OTHER" }, { "name": "End of Life Care Workshop", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 337, "start_date": "2018-10-10", "completion_date": "2019-08-03", "has_results": false, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-11-07T19:54:28.082Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04443114" }, { "nct_id": "NCT06293898", "title": "Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Endometrial Cancer", "Cervical Cancer", "Ovarian Cancer", "Urothelial Carcinoma", "Biliary Tract Cancer", "Breast Cancer", "Lung Cancer", "Gastric Cancer", "Gastroesophageal-junction Cancer", "Esophageal Cancer" ], "interventions": [ { "name": "BL-M07D1", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SystImmune Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 280, "start_date": "2024-02-09", "completion_date": "2029-04-15", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-11-07T19:54:28.082Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Duarte, California • Los Angeles, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06293898" }, { "nct_id": "NCT06325748", "title": "SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "AML/MDS", "CD33 Expressing Hematological Malignancies", "FLT3 Expressing Hematological Malignancies" ], "interventions": [ { "name": "SENTI-202", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Senti Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 21, "start_date": "2024-04-22", "completion_date": "2040-08", "has_results": false, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-11-07T19:54:28.082Z", "location_count": 6, "location_summary": "Los Angeles, California • Denver, Colorado • Jacksonville, Florida + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06325748" }, { "nct_id": "NCT04084769", "title": "Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Immunisation (Healthy Volunteers)" ], "interventions": [ { "name": "Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine MenACYW Conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal Group B vaccine (Trumenba®)", "type": "BIOLOGICAL" }, { "name": "Meningococcal group B vaccine (Bexsero®)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "26 Years", "sex": "ALL", "summary": "13 Years to 26 Years" }, "enrollment_count": 570, "start_date": "2019-09-03", "completion_date": "2020-09-14", "has_results": true, "last_update_posted_date": "2025-09-15", "last_synced_at": "2026-11-07T19:54:28.082Z", "location_count": 29, "location_summary": "Birmingham, Alabama • San Diego, California • Bardstown, Kentucky + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Bridgeton", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04084769" }, { "nct_id": "NCT03645395", "title": "Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-hodgkin Lymphoma" ], "interventions": [ { "name": "MT-3724", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Molecular Templates, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "101 Years", "sex": "ALL", "summary": "18 Years to 101 Years" }, "enrollment_count": 9, "start_date": "2019-04-08", "completion_date": "2021-03-10", "has_results": true, "last_update_posted_date": "2022-08-16", "last_synced_at": "2026-11-07T19:54:28.082Z", "location_count": 5, "location_summary": "Whittier, California • Plantation, Florida • Chicago, Illinois + 2 more", "locations": [ { "city": "Whittier", "state": "California" }, { "city": "Plantation", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03645395" }, { "nct_id": "NCT04619043", "title": "Understanding the Effects of Quantitatively-Prescribing Passive-Dynamic Ankle-Foot Orthosis Bending Stiffness for Individuals Post-Stroke", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gait, Hemiplegic" ], "interventions": [ { "name": "Ankle Orthotic", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Delaware", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 32, "start_date": "2016-01", "completion_date": "2023-06", "has_results": false, "last_update_posted_date": "2023-09-15", "last_synced_at": "2026-11-07T19:54:28.082Z", "location_count": 1, "location_summary": "Newark, Delaware", "locations": [ { "city": "Newark", "state": "Delaware" } ], "official_url": "https://clinicaltrials.gov/study/NCT04619043" } ] }